Searching for keyword:"AP30663"

1 result
Record publications over time
Ironsift results are limited for unregistered users. Register or log in to see all records.

EU Clinical Trial 2018-004445-17 – EMA – May 30, 2019

A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group Study of AP30663 Given Intravenously for Cardioversion in Patients with Atrial Fibrillation

Main objective of the trial: The primary objective of the study is to demonstrate efficacy of AP30663 on the basis of the ability to convert AF following intravenous administration.
Full record